Georges Ibrahim

Georges Ibrahim has a diverse work experience in the pharmaceutical and medical technology industries. Georges has held various leadership roles in different companies, demonstrating their expertise in quality management and production.

Georges began their career at Eli Lilly and Company as a Quality Engineer, where they implemented an improved Quality system for the production site in France. Georges then joined Becton, Dickinson and Company as a QA Manager, leading a greenfield project to establish a new business unit for the development and manufacturing of generic injectable drugs.

After that, Georges worked at Stryker as a Process Owner, where they focused on the development and optimization of cleaning and packaging lines for sterile implants. Georges also led the implementation of a new facility dedicated to these activities.

Georges then joined Novartis and held various roles, including Global Quality Systems Manager at Sandoz, and Site Quality Head at different Novartis sites. Georges achieved significant improvements in quality and compliance at these sites, contributing to the company's success in the market.

Most recently, Georges was the Chief Technical Officer and Chief Quality Officer at Julphar, one of the largest pharmaceutical manufacturers in the Middle East and North Africa region. Georges successfully managed internationally certified manufacturing facilities and contributed to the company's significant revenue growth.

Currently, Georges is serving as the Chief Quality Officer at Tabuk Pharmaceuticals Manufacturing Company, where they continue to drive excellence in quality management.

Georges Ibrahim earned a Bachelor's degree in Chemistry from Saint Joseph University of Beirut in 2001. Georges then pursued a Master's degree in Chemical Process from Université de Technologie de Compiègne (UTC) between 2001 and 2003. Lastly, they completed a Master's degree in Quality and Organisations from INSA Strasbourg in 2005.